Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

4/1/2012

Botox Sales Increasing as Beauty Fans Seek No-Knife Alternative

Botox will continue its reign as a bestseller in US beauty clinics due to competitive pricing and reductions in side effects. Botox in particular is predicted to maintain its lead in terms of market share during future years, due to increased patient comfort, short procedure times and immediate results. The ingredients used in botox degrade within six months, which means that both the results from treatment, as well as any adverse side effects, are temporary. This acts to lower the risks of treatment and improve the rate of income for practitioners. High levels of competition in the future market will result in decreasing price trends in the US, encouraging further popularity. The global botox market is forecast to reach $2.9 billion by 2018 at a CAGR of 14%.


Long-Term Market Growth Depends Upon Ability to Extend Longevity of Results to Compete Against Cosmetic Surgery
The dermal fillers market will grow in the future due to the increasing consumer preference for hyaluronic acid-based dermal fillers (HA fillers), which offer fewer side effects in exchange for results lasting just three to six months. This may be good news for aesthetic centers, as HA fillers will provide recurring income. In contrast, the Particle and Polymer Fillers (PPF) market is expected to struggle, as the longevity of aesthetic results lasting up to two years is countered by a higher side effects profile. Currently, no facial aesthetic procedure can offer permanency, and the longevity of results correlates with higher medical risks. Long-term market growth may depend upon the ability to extend the longevity of results from facial injections, in order to compete more strongly against cosmetic surgery. The entire global market for facial aesthetics is forecast to reach $4.7 billion in 2018, of which the US is expected to contribute over US$2 billion.

GlobalData's report "Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global facial aesthetics market. It gives the market landscape, competitive landscape and market trends information for the facial aesthetics market, and provides comprehensive information on the key trends affecting the market, as well as key analytical content. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

This report will provide you with...

Key geographies covered are the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil

Key segments covered include Botulinum Toxin (Botox) and Dermal Fillers (HA fillers and Other Dermal Fillers)

Annualized market revenue data for 2011 and forecast to 2018

Company shares data for 2011

Company shares data for Botox and Dermal Fillers for 2011

Qualitative analysis of key market trends, market drivers, and restraints within the facial aesthetics market

Information on the leading market players, competitive landscape, and leading pipeline products and technologies

The key players covered are Allergan, Q-Med, Mentor, Medicis and Merz.

Back

Archives

GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved